½ÃÀ庸°í¼­
»óǰÄÚµå
1703445

Ű³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, À¯Çüº°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)

Kinase Biology Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application By Region & Competition, 2020-2030F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ű³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 10¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â±îÁö ¿¬Æò±Õ 10.02%ÀÇ °ßÁ¶ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

Ű³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ¼¼°è ½ÃÀåÀº ±¤¹üÀ§ÇÑ »ý¸í°úÇÐ ¹× Á¦¾à »ê¾÷¿¡¼­ Áß¿äÇÏ°í ¿ªµ¿ÀûÀÎ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ¼¼Æ÷ °úÁ¤À» Á¶ÀýÇÏ´Â È¿¼ÒÀÇ ÀÏÁ¾ÀΠŰ³ª¾ÆÁ¦´Â ½Å¾à°³¹ß ¹× ¾à¹° °³¹ß¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Ű³ª¾ÆÁ¦´Â ¼¼Æ÷ÀÇ ¼ºÀå, Áõ½Ä, ºÐÈ­, ¼¼Æ÷»ç¸êÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ »ý¹°ÇÐÀû °úÁ¤ÀÇ Á¶Àý¿¡ °ü¿©Çϰí ÀÖ½À´Ï´Ù. Ű³ª¾ÆÁ¦ÀÇ Á¶Àý ÀÌ»óÀº Á¾Á¾ ¾Ï, ¿°Áõ¼º Áúȯ, ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº Áúº´°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 10¾ï 8,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 19¾ï 2,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 10.02%
±Þ¼ºÀå ºÎ¹® ELISA ±â¹Ý °Ë»ç
ÃÖ´ë ½ÃÀå ºÏ¹Ì

±× °á°ú, Ű³ª¾ÆÁ¦ ¿¬±¸´Â Áúº´ ¸ÞÄ¿´ÏÁòÀ» ±Ô¸íÇϰí ÀáÀçÀûÀÎ Ä¡·á Ç¥ÀûÀ» ã´Â µ¥ ÇÙ½ÉÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¼°è ¿¬±¸ ½ÃÀå¿¡´Â Ű³ª¾ÆÁ¦ °ü·Ã ¿¬±¸¸¦ Áö¿øÇϱâ À§ÇØ Á¶Á¤µÈ ´Ù¾çÇÑ ¼­ºñ½º¿Í Á¦Ç°ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º¿¡´Â Ű³ª¾ÆÁ¦ ºÐ¼® °³¹ß, ÇÏÀ̽º·çDz ½ºÅ©¸®´×, Ű³ª¾ÆÁ¦ ÇÁ·ÎÆÄÀϸµ, Ű³ª¾ÆÁ¦ ¾ïÁ¦Á¦ ½ºÅ©¸®´× µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º¸¦ ÅëÇØ Á¦¾àȸ»ç, »ý¸í°øÇÐ ±â¾÷, Çаè, ¿¬±¸±â°üÀº ÀáÀçÀûÀÎ ÀǾàǰ Èĺ¸¹°Áú·Î »ç¿ëÇÒ ¼ö Àִ Ű³ª¾ÆÁ¦ ¾ïÁ¦Á¦¸¦ ½Äº°ÇÏ°í Æ¯¼ºÈ­ÇÏ¿© ½Å¾à°³¹ßÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¾Ï°ú ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡

ÁÖ¿ä ½ÃÀå À̽´

Ű³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½ºÀÇ ³ôÀº ºñ¿ë

ÁÖ¿ä ½ÃÀå µ¿Çâ

Ç¥ÀûÄ¡·á¿Í ¸ÂÃãÀÇ·á

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • À¯Çüº°(ELISA ±â¹Ý Å×½ºÆ®, È¿¼Ò Å×½ºÆ®, ºñ»ö ¾î¼¼ÀÌ ±â¹Ý Å×½ºÆ®, ±âŸ)
    • ¿ëµµº°(Áø´Ü¿ë, ¿¬±¸¿ë)
    • ±â¾÷º°(2024³â)
    • Áö¿ªº°
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ¸ß½ÃÄÚ
    • ij³ª´Ù

Á¦7Àå À¯·´ÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ÀϺ»
    • È£ÁÖ

Á¦9Àå ³²¹ÌÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Å°³ª¾ÆÁ¦ »ý¹°ÇÐ ¼­ºñ½º ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

  • ÃÖ±Ù µ¿Çâ
  • Á¦Ç° Ãâ½Ã
  • ÀμöÇÕº´(M&A)

Á¦13Àå PESTEL ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

  • ¾÷°è³» °æÀï
  • ½Å±Ô Âü¿© °¡´É¼º
  • °ø±Þ¾÷üÀÇ Èû
  • °í°´ÀÇ Èû
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd
  • Jena Bioscience GmbH
  • Qiagen N.V.
  • Merck & Co., Inc
  • Promega Corporation
  • Takara Bio Inc.
  • Reaction Biology Corporation(RBC)
  • Nanosyn

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ¸®¼­Ä¡»ç¿¡ ´ëÇØ & ¸éÃ¥»çÇ×

LSH 25.04.25

Global Kinase Biology Services Market was valued at USD 1.08 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.02% through 2030. The Global Kinase Biology Services Market has emerged as a critical and dynamic sector within the broader life sciences and pharmaceutical industries. Kinases, a class of enzymes that regulate various cellular processes, have gained immense importance in drug discovery and development, making kin Kinases are involved in the regulation of diverse biological processes, including cell growth, proliferation, differentiation, and apoptosis. Dysregulation of kinases is often associated with diseases such as cancer, inflammatory disorders, and neurodegenerative conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.08 Billion
Market Size 2030USD 1.92 Billion
CAGR 2025-203010.02%
Fastest Growing SegmentELISA Based Tests
Largest MarketNorth America

Consequently, the study of kinases has become central to understanding disease mechanisms and identifying potential therapeutic targets. The Global Kinase Biology Services Market encompasses a wide range of services and products tailored to support kinase-related research. These services include kinase assay development, high-throughput screening, kinase profiling, and kinase inhibitor screening, among others. They enable pharmaceutical and biotechnology companies, academic institutions, and research organizations to accelerate drug discovery by identifying and characterizing kinase inhibitors, which can be used as potential drug candidates.

Key Market Drivers

Rising Prevalence of Cancer and Chronic Diseases

Kinases are enzymes that regulate a wide range of cellular processes, including cell growth, division, and survival. In cancer and several chronic diseases, dysregulation of kinase activity is a common molecular hallmark. This makes kinases high-value therapeutic targets, especially in the development of targeted therapies and precision medicines. In 2022, global cancer incidence reached an estimated 20 million new cases, resulting in 9.7 million deaths. Additionally, approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting the increasing burden on healthcare systems and long-term care infrastructure. As the global burden of diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases continues to rise, there is a corresponding increase in demand for effective and targeted treatments. This creates a strong commercial incentive for pharmaceutical and biotechnology companies to focus their R&D efforts on kinase-related pathways, which in turn boosts demand for specialized kinase biology services.

Key Market Challenges

High Cost of Kinase Biology Services

The Global Kinase Biology Services Market has emerged as a critical player in the realm of drug discovery and disease understanding. Kinases, enzymes that regulate various cellular processes, hold immense potential in the development of targeted therapies. One primary reason for the elevated costs in kinase biology services is the complexity of the field itself. Kinase signaling pathways are intricate and multifaceted, requiring specialized knowledge, expertise, and cutting-edge technologies for their study. This complexity necessitates the involvement of skilled researchers and technicians who are well-versed in kinase biology, adding to the overall expenses. Another cost-driving factor is the need for sophisticated equipment and resources. Kinase assays, high-throughput screening, kinase profiling, and other related services rely heavily on state-of-the-art laboratory instrumentation. Maintaining and operating these tools, along with the cost of consumables and reagents, contribute significantly to the overall service fees. The high cost of kinase biology services can result in limited accessibility, particularly for smaller biotechnology companies, academic institutions, and emerging startups with constrained budgets. This accessibility gap can stifle innovation and prevent potentially groundbreaking research from reaching its full potential. It may also deter smaller entities from pursuing kinase-related projects, which could otherwise contribute significantly to the market's growth.

Key Market Trends

Targeted Therapies and Personalized Medicine

In the era of targeted therapies, the emphasis is on identifying and inhibiting specific molecular targets responsible for disease initiation and progression. Kinases frequently feature as these targets due to their central role in many diseases, making them attractive candidates for drug discovery efforts. The Global Kinase Biology Services Market is witnessing a surge in demand as pharmaceutical companies, research institutions, and biotechnology firms seek specialized services to identify and validate kinase inhibitors tailored to individual patients' genetic profiles. Personalized medicine hinges on the notion that every patient is unique, and treatments should reflect this individuality. As a result, kinase biology services have gained prominence in analyzing patients' genetic makeup to pinpoint the specific mutations or alterations in kinase activity driving their diseases. By tailoring therapies based on these genetic insights, clinicians can optimize treatment strategies, increasing efficacy and minimizing side effects. The application of personalized medicine extends beyond cancer, encompassing various chronic and rare diseases where kinase biology plays a pivotal role. This broadens the scope of the Kinase Biology Services Market, as researchers and pharmaceutical companies delve into the development of targeted therapies for conditions such as neurodegenerative disorders, autoimmune diseases, and cardiovascular ailments.

Key Market Players

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd
  • Jena Bioscience GmbH
  • Qiagen N.V.
  • Merck & Co., Inc
  • Promega Corporation
  • Takara Bio Inc.
  • Reaction Biology Corporation (RBC)
  • Nanosyn

Report Scope:

In this report, the Global Kinase Biology Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Biology Services Market, By Type:

  • ELISA Based Tests
  • Enzymatic Tests
  • Colorimetric Assay Based Tests
  • Others

Kinase Biology Services Market, By Application:

  • Diagnosis Use
  • Research Use

Kinase Biology Services Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kinase Biology Services Market.

Available Customizations:

Global Kinase Biology Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Biology Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (ELISA Based Tests, Enzymatic Tests, Colorimetric Assay Based Tests, Others)
    • 5.2.2. By Application (Diagnosis Use, Research Use)
    • 5.2.3. By Company (2024)
    • 5.2.4. By Region
  • 5.3. Market Map

6. North America Kinase Biology Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kinase Biology Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Kinase Biology Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Kinase Biology Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Kinase Biology Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Kinase Biology Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Kinase Biology Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Kinase Biology Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Kinase Biology Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Kinase Biology Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Kinase Biology Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Kinase Biology Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Kinase Biology Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Kinase Biology Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Kinase Biology Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Kinase Biology Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Kinase Biology Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Kinase Biology Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Kinase Biology Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Kinase Biology Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Kinase Biology Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Kinase Biology Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Kinase Biology Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Kinase Biology Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific
    • 15.1.1. Business Overview
    • 15.1.2. Product & Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (If Listed)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd
  • 15.3. Jena Bioscience GmbH
  • 15.4. Qiagen N.V.
  • 15.5. Merck & Co., Inc
  • 15.6. Promega Corporation
  • 15.7. Takara Bio Inc.
  • 15.8. Reaction Biology Corporation (RBC)
  • 15.9.Nanosyn

16. Strategic Recommendations

17. About Us & Disclaimer

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦